Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
94.25
-0.35 (-0.37%)
Nov 21, 2024, 11:09 AM EST - Market open
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $4.57 billion as of November 21, 2024. Its market cap has increased by 54.64% in one year.
Market Cap
4.57B
Enterprise Value
4.45B
1-Year Change
54.64%
Ranking
Category
Stock Price
$94.25
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $4.57B, an increase of 2,848.73%. That is a compound annual growth rate of 45.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 4.63B | 22.83% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PROCEPT BioRobotics | 5.02B |
| Stevanato Group | 4.99B |
| Select Medical Holdings | 4.91B |
| Biohaven | 4.74B |
| Arcellx | 4.72B |
| Alkermes | 4.52B |
| Integer Holdings | 4.47B |
| TG Therapeutics | 4.47B |